InMed Pharmaceuticals (INM) Gross Profit Growth (1y) (2022 - 2025)
InMed Pharmaceuticals (INM) Gross Profit Growth (1y) (2022 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Gross Profit Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.92 Bn | 42.96 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.19 Bn | 39.53 Bn | 2.15 Bn | 2.43% |
| 3 | Zoetis | 31.74 Bn | 30.06 Bn | 1.05 Bn | -8.36% |
| 4 | Takeda Pharmaceutical | 28.67 Bn | 22.87 Bn | 5.10 Bn | -5.56% |
| 5 | United Therapeutics | 22.22 Bn | 19.56 Bn | 683.80 Mn | -3.83% |
| 6 | Viatris | 18.71 Bn | 17.83 Bn | 1.46 Bn | 9.27% |
| 7 | Neurocrine Biosciences | 15.55 Bn | 15.16 Bn | 935.80 Mn | 38.19% |
| 8 | Elanco Animal Health | 11.80 Bn | 11.27 Bn | 798.00 Mn | 11.92% |
| 9 | Dr Reddys Laboratories | 10.13 Bn | 9.97 Bn | - | - |
| 10 | InMed Pharmaceuticals | 6.48 Mn | 1.24 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -60.04% |
| Sep 30, 2025 | -18.29% |
| Jun 30, 2025 | 23.73% |
| Mar 31, 2025 | -39.33% |
| Dec 31, 2024 | 42.19% |
| Sep 30, 2024 | 2,222.82% |
| Jun 30, 2024 | -70.32% |
| Mar 31, 2024 | 50.36% |
| Dec 31, 2023 | 147.13% |
| Sep 30, 2023 | 104.33% |
| Jun 30, 2023 | 528.87% |
| Mar 31, 2023 | 5.61% |
| Dec 31, 2022 | 17.58% |